- Home
- WPM vs BSX Comparison
WPM vs BSX Comparison
Compare WPM & BSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WPM | BSX |
|---|---|---|
| Founded | 2004 | 1979 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Precious Metals | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.9B | 68.0B |
| IPO Year | 2005 | 2010 |
Fundamental Metrics
Financial Performance| Metric | WPM | BSX |
|---|---|---|
| Price | $136.03 | $43.31 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 16 | 31 |
| Target Price | ★ $178.31 | $59.72 |
| AVG Volume (30 Days) | 1.5M | ★ 16.6M |
| Earning Date | 11-05-2026 | 10-28-2026 |
| Dividend Yield | ★ 0.54% | N/A |
| EPS Growth | N/A | ★ 55.20 |
| EPS | N/A | ★ 1.51 |
| Revenue | N/A | ★ $9,076,000,000.00 |
| Revenue This Year | $59.20 | $5.49 |
| Revenue Next Year | $10.37 | $4.84 |
| P/E Ratio | $65.73 | ★ $28.97 |
| Revenue Growth | N/A | ★ 12.49 |
| 52 Week Low | $92.57 | $41.39 |
| 52 Week High | $165.76 | $105.65 |
Technical Indicators
Market Signals| Indicator | WPM | BSX |
|---|---|---|
| Relative Strength Index (RSI) | 44.27 | 47.03 |
| Support Level | $130.22 | $42.49 |
| Resistance Level | $153.21 | $46.06 |
| Average True Range (ATR) | 3.25 | 0.99 |
| MACD | -0.41 | 0.17 |
| Stochastic Oscillator | 38.53 | 57.62 |
Price Performance
Historical ComparisonAbout WPM Wheaton Precious Metals Corp (Canada)
Wheaton Precious Metals Corp is a precious metal streaming company. Its geographical segment includes: North America; Europe; South America; and Africa. It generates its revenue from the sale of precious metals (gold, silver and palladium) and cobalt.
About BSX Boston Scientific Corporation
Boston Scientific focuses on less invasive medical devices that are inserted into the human body through small openings or cuts. It manufactures products for use in angioplasty, blood clot filtration, kidney stone management, cardiac rhythm management, catheter-directed ultrasound imaging, upper gastrointestinal tract diagnostics, interventional oncology, neuromodulation for chronic pain, and treatment of incontinence. The firm markets its devices to healthcare professionals and institutions globally. Foreign sales account for roughly 36% of the firm's total sales.